Selank is a synthetic peptide derived from Tuftsin, a naturally occurring immunomodulatory peptide that plays a key role in immune regulation and neuroprotection. Originally developed for the treatment of generalized anxiety disorder (GAD), Selank exhibits potent anxiolytic, nootropic, and immunomodulating properties.
Often referred to as the “benzodiazepine of the peptide world,” Selank provides similar calming and anti-anxiety effects to drugs like diazepam, but without sedation, tolerance, or addictive potential. Clinical studies have shown Selank to outperform diazepam in both efficacy and safety profile.
Benefits
- Reduces anxiety and stress — Promotes a sense of calm without drowsiness or dependency.
- Improves focus, learning, and memory — Supports enhanced cognitive function and mental clarity.
- Enhances mood and reduces depression — Regulates neurotransmitters such as serotonin and dopamine.
- Strengthens immune function — Stimulates macrophage activity and interferon secretion, aiding defense against viral and microbial infections.
- Protects against brain damage — Provides neuroprotection from ischemic injury, oxidative stress, and neurotoxin exposure.
- Aids in recovery from brain trauma or stroke — May help preserve and restore cognitive function post-injury.
- Prevents memory decline — Counters brain-derived neurotrophic factor (BDNF) dysregulation in the hippocampus and frontal cortex.
- Supports mental resilience — Improves emotional stability and reduces the cognitive effects of chronic stress.
- Can be combined with SSRIs — Enhances antidepressant effects without interaction risks.
Mechanism of Action
Selank acts by:
- Modulating neurotransmitters, particularly serotonin, dopamine, and norepinephrine, to stabilize mood and cognition.
- Stimulating interferon production, improving immune system response to pathogens.
- Activating macrophages and lymphocytes, enhancing immune surveillance.
- Increasing BDNF expression, which supports neurogenesis and protects against cognitive decline.
- Balancing GABAergic activity, similar to benzodiazepines but without tolerance buildup.
Clinical Insights
- Shown to outperform recombinant interferon-A in antiviral studies, particularly against the influenza virus.
- Demonstrated neuroprotective benefits in models of alcohol-induced cognitive impairment and ischemic brain injury.
- Considered safe for long-term use with no evidence of withdrawal or dependency.
